描述
Mixed Protamine Human Insulin 30R Description
Product name: Protamine human insulin mixed injection (30R) (Ibilin 30/Dongyangguang)
Packing specification: 3ml: 300 units (pen refill) ? Product dosage form: injection ? Packaging unit: stick/box
Approval number: National Medicine Standard S20230051 ? Drug standard code: 86980955000174
Manufacturer: Yichang Dongyangguang Changjiang Pharmaceutical Co., Ltd.
Product barcode: 6933346880941
Mixed Protamine Human Insulin 30R (commonly known as NPH-based 30R mix) consists of 30% fast-acting regular human insulin and 70% intermediate-acting NPH (Neutral Protamine Hagedorn) insulin. This premixed formulation is widely used in diabetes treatment, offering dual-phase insulin absorption: rapid onset (~1.5–2.5 hrs) followed by sustained action (~24 hrs) .
It is presented in a 3?ml prefilled pen cartridge containing 300 IU, designed for use with insulin pen injectors. Developed under NMPA approval S20230051, product code 86980955000174, and barcode 6933346880941.
This format is well-suited for pharmacodynamic studies, insulin regimen modeling, device testing, and metabolic research requiring both basal and mealtime insulin cover.
? Product Specifications
Feature | Details |
---|---|
Product Name | Mixed Protamine Human Insulin Injection (30R) – Yibolin 30 |
Strength | 300 International Units (IU) per 3 ml (100 IU/ml) |
Composition | 30% regular human insulin, 70% NPH insulin |
Dosage Form | Prefilled insulin pen cartridge |
Volume | 3 ml (300 IU total) |
Manufacturer | Yichang Dongyangguang Changjiang Pharma Co., Ltd |
Approval Number (NMPA) | S20230051 |
Product Code | 86980955000174 |
Barcode | 6933346880941 |
Appearance | White to off-white suspension; crystals dissolve with rolling shake |
Onset of Action | ~1.5–2.5 hours |
Peak Action (Regular Insulin) | ~1.5–3 hrs |
Duration of Action (NPH) | Up to ~24 hours |
Storage | Refrigerated at 2–8?°C; do not freeze |
Shelf Life | As labeled; typically 24 months |
Intended Use | Laboratory research / insulin regimen modeling |
?? Mechanism & Pharmacokinetic Profile
-
Dual-Phase Insulin Delivery:
-
Regular insulin offers immediate post-meal blood sugar control.
-
NPH provides basal insulin coverage.
-
-
Premix Advantage: Enables simplified dosing in preclinical insulin regimen design.
-
Pharmacokinetics:
-
Rapid component peaks in 1.5–2.5 hrs.
-
Intermediate NPH peaks and sustains controlled glucose release up to 24 hrs .
-
Why Choose Yibolin 30R Pen Cartridge?
-
Dual-phase insulin mix in a single-cartridge format
-
Preferred for preclinical insulin regimen development
-
Fully traceable via NMPA approval and barcode
-
Ideal for metabolic, endocrinology, and pharmacokinetic studies
-
Regular Human Insulin Vials (100 IU/ml)
-
NPH Insulin Suspensions
-
Rapid-Acting Analogs (Aspart, Lispro)
Summary
Yibolin 30R Mixed Protamine Human Insulin 300?IU pen cartridge offers a research-grade dual-phase insulin in a ready-to-use format. With fast and intermediate action combined, traceable batch approvals, and ideal structure for diabetes modeling—it’s a valuable tool for metabolic research.
?? For laboratory research or analytical use only — not for human consumption or therapy.
kuba –
Nice packaging, thank you